Litcius/Paper detail

Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients

Louise Benning, Christian Morath, Marie Bartenschlager, Heeyoung Kim, Marvin Reineke, Jörg Beimler, Mirabel Buylaert, Christian Nußhag, Florian Kälble, Paula Reichel, Maximilian Töllner, Matthias Schaier, Katrin Klein, Vladimı́r Beneš, Tobias Rausch, Susanne Rieger, Maximilian Stich, Burkhard Tönshoff, Niklas Weidner, Paul Schnitzler, Martin Zeier, Caner Süsal, Thuong Hien Tran, Ralf Bartenschlager, Claudius Speer

2022American Journal of Transplantation48 citationsDOIOpen Access PDF

Topics & Concepts

SeroconversionMedicineNeutralizationAntibodyVirologyNeutralizing antibodyKidney transplantationTiterVaccinationImmunologyKidneyInternal medicineSARS-CoV-2 and COVID-19 ResearchHeparin-Induced Thrombocytopenia and ThrombosisAnimal Virus Infections Studies
Neutralizing antibody response against the B.1.617.2 (delta) and the B.1.1.529 (omicron) variants after a third mRNA SARS-CoV-2 vaccine dose in kidney transplant recipients | Litcius